www.acaai.org/acaai-cms/Templates/member.aspx?NRMODE=Pu -
[Cached Version]
Published on: 11/4/2005
Last Visited: 12/8/2007
ACAAI President Myron Zitt, MD, reviewed the role of the House of Delegates and the importance of the feedback that it provides to the Board of Regents.He thanked the Speaker for her work in bringing a "town hall" forum structure to the meeting and encouraged ACAAI members to use the House of Delegates page on the ACAAI Web site.
He reviewed the positive resolution of the immunotherapy issue with New York Empire Blue Cross/Blue Shield.He stated that this was an example of the House of Delegates bringing an issue to the Board of Regents.
In addition, he discussed the issue of the AAFA Seal of Approval that has been awarded to ionizer products.He said that AAFA had informed him that ionizers would no longer be endorsed after Jan. 1.
...
Thanks to the team that accomplished this great feat: Dan Mayer, MD (Past president, LIAAS/NYSSAAI), Robert Corriel, MD (President, LIAAS), Jim Pollowitz, MD (President, NYSSAAI), Andy Green, MD (Past President, NYSSAAI), Robert Scher, MD(President, MSSNY), Myron Zitt,MD (President , ACAAI), Michael Schatz, MD (President, AAAAI), Stan Fineman, MD (President, JCAAI), Linda Cox, MD (Chair , AAAAI Immunotherapy and Allergy Diagnostics Committee), John Cohn, MD (Chair, AAAAI Practice Diagnostic and Therapeutics Committee) and the Texas and Florida allergy societies.